HMOX1 and systemic lupus erythematosus: Furthermore, lupus animal experiments have demonstrated that inducing HO-1 or inhibiting the phosphatidylinositol 3-kinase (PI3K)/mammalian target of the rapamycin (mTOR)-mediated pathway may potentially reduce RSI expression, leading to the amelioration of LN [36,37].